Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial

Jana B Ernst, Andreas Tomaschitz, Martin R Grübler, Martin Gaksch, Katharina Kienreich, Nicolas Verheyen, Winfried März, Stefan Pilz, Armin Zittermann, Jana B Ernst, Andreas Tomaschitz, Martin R Grübler, Martin Gaksch, Katharina Kienreich, Nicolas Verheyen, Winfried März, Stefan Pilz, Armin Zittermann

Abstract

Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels <75 nmol/L who attended the Styrian Vitamin D Hypertension Trial were included, of whom 188 completed the trial. Patients randomly received 2800 IU vitamin D3 daily or a matching placebo for eight weeks. Initially, the prevalence of anemic status (Hb levels <12.5 g/dL) and deficient 25OHD levels (<30 nmol/L) was 6.5% and 7.5%, respectively. All anemic patients had 25OHD levels >50 nmol/L. The mean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels <30 nmol/L. In conclusion, a daily vitamin D supplement of 2800 IU for eight weeks did not improve Hb levels or anemic status in hypertensive patients. Future trials should focus on anemic patients with deficient 25OHD levels (e.g., <30 nmol/L). This trial is registered with clinicaltrials.gov [NCT02136771].

Figures

Figure 1
Figure 1
Anemia proportion in participants of the Styrian Vitamin D Hypertension Trial at baseline and study termination (by study group). P values indicated within study group results.

References

    1. McLean E., Cogswell M., Egli I., Wojdyla D., de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutrition. 2009;12(4):444–454. doi: 10.1017/s1368980008002401.
    1. Nissenson A. R., Goodnough L. T., Dubois R. W. Anemia: not just an innocent bystander? Archives of Internal Medicine. 2003;163(12):1400–1404. doi: 10.1001/archinte.163.12.1400.
    1. Zittermann A., Prokop S. The role of vitamin D for cardiovascular disease and overall mortality. Advances in Experimental Medicine and Biology. 2014;810:106–119.
    1. Ernst J. B., Becker T., Kuhn J., Gummert J. F., Zittermann A. Independent association of circulating vitamin d metabolites with anemia risk in patients scheduled for cardiac surgery. PLoS ONE. 2015;10(4) doi: 10.1371/journal.pone.0124751.e0124751
    1. Zittermann A., Jungvogel A., Prokop S., et al. Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clinical Research in Cardiology. 2011;100(9):781–788. doi: 10.1007/s00392-011-0312-5.
    1. Zittermann A., Kuhn J., Dreier J., et al. Association of 25-hydroxyvitamin D with anemia risk in patients scheduled for cardiac surgery. International Journal of Laboratory Hematology. 2014;36(1):29–36. doi: 10.1111/ijlh.12112.
    1. Perlstein T. S., Pande R., Berliner N., Vanasse G. J. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood. 2011;117(10):2800–2806. doi: 10.1182/blood-2010-09-309708.
    1. Patel N. M., Gutiérrez O. M., Andress D. L., Coyne D. W., Levin A., Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney International. 2010;77(8):715–720. doi: 10.1038/ki.2009.551.
    1. Smith E. M., Alvarez J. A., Martin G. S., Zughaier S. M., Ziegler T. R., Tangpricha V. Vitamin d deficiency is associated with anaemia among african americans in a us cohort. British Journal of Nutrition. 2015;113(11):1732–1740. doi: 10.1017/s0007114515000999.
    1. Sim J. J., Lac P. T., Liu I. L. A., et al. Vitamin D deficiency and anemia: a cross-sectional study. Annals of Hematology. 2010;89(5):447–452. doi: 10.1007/s00277-009-0850-3.
    1. Lee J. A., Hwang J. S., Hwang I. T., Kim D. H., Seo J. H., Lim J. S. Low vitamin d levels are associated with both iron deficiency and anemia in children and adolescents. Journal of Pediatric Hematology/Oncology. 2015;32(2):99–108. doi: 10.3109/08880018.2014.983623.
    1. Atkinson M. A., Melamed M. L., Kumar J., et al. Vitamin D, race, and risk for anemia in children. Journal of Pediatrics. 2014;164(1):153.e1–158.e1. doi: 10.1016/j.jpeds.2013.08.060.
    1. Kendrick J., Targher G., Smits G., Chonchol M. 25-Hydroxyvitamin d deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. American Journal of Nephrology. 2009;30(1):64–72. doi: 10.1159/000202632.
    1. Kiss Z., Ambrus C., Almasi C., et al. Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron—Clinical Practice. 2011;117(4):c373–c378. doi: 10.1159/000321521.
    1. Yoo E.-H., Cho H.-J. Prevalence of 25-hydroxyvitamin d deficiency in korean patients with anemia. Journal of Clinical Laboratory Analysis. 2015;29(2):129–134. doi: 10.1002/jcla.21740.
    1. Goicoechea M., Vazquez M. I., Ruiz M. A., Gomez-Campdera F., Perez-García R., Valderrábano F. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron. 1998;78(1):23–27. doi: 10.1159/000044877.
    1. Neves P. L., Triviño J., Casaubon F., et al. Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol. International Urology and Nephrology. 2006;38(1):175–177. doi: 10.1007/s11255-004-1563-0.
    1. Nazem A. K., Makó J. The effect of calcitriol on renal anaemia in patients undergoing long-term dialysis. International Urology and Nephrology. 1997;29(1):119–127. doi: 10.1007/bf02551427.
    1. Djordjevic V., Radivojevic J., Stefanovic V. Improvement of anemia in hemodialysis patients after pulse oral 1-alpha-d3 treatment. Clinical Nephrology. 2002;57(6):487–488. doi: 10.5414/cnp57487.
    1. Albitar S., Genin R., Fen-Chong M., Serveaux M.-O., Schohn D., Chuet C. High-dose alfacalcidol improves anaemia in patients on haemodialysis. Nephrology Dialysis Transplantation. 1997;12(3):514–518. doi: 10.1093/ndt/12.3.514.
    1. Kumar V. A., Kujubu D. A., Sim J. J., Rasgon S. A., Yang P. S. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. Journal of Nephrology. 2011;24(1):98–105. doi: 10.5301/jn.2010.1830.
    1. Saab G., Young D. O., Gincherman Y., Giles K., Norwood K., Coyne D. W. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clinical Practice. 2007;105(3):c132–c138. doi: 10.1159/000098645.
    1. Rianthavorn P., Boonyapapong P. Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5. Pediatric Nephrology. 2013;28(8):1261–1266. doi: 10.1007/s00467-013-2431-x.
    1. Sooragonda B., Bhadada S. K., Shah V. N., Malhotra P., Ahluwalia J., Sachdeva N. Effect of vitamin d replacement on hemoglobin concentration in subjects with concurrent iron-deficiency anemia and vitamin d deficiency: a randomized, single-blinded, placebo-controlled trial. Acta Haematologica. 2015;133(1):31–35. doi: 10.1159/000357104.
    1. Zheng Y. T., Cui Q. Q., Hong Y. M., Yao W. G. A meta-analysis of high dose, intermittent vitamin D supplementation among older adults. PLoS ONE. 2015;10(1) doi: 10.1371/journal.pone.0115850.e0115850
    1. Pilz S., Gaksch M., Kienreich K., et al. Effects of vitamin d on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension. 2015;65(6):1195–1201. doi: 10.1161/HYPERTENSIONAHA.
    1. Heaney R. P. Vitamin D in health and disease. Clinical Journal of the American Society of Nephrology. 2008;3(5):1535–1541. doi: 10.2215/cjn.01160308.
    1. Holick M. F. Vitamin D deficiency. The New England Journal of Medicine. 2007;357(3):266–281. doi: 10.1056/nejmra070553.
    1. Karkouti K., Wijeysundera D. N., Beattie W. S. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation. 2008;117(4):478–484. doi: 10.1161/circulationaha.107.718353.
    1. Levey A. S., Bosch J. P., Lewis J. B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Annals of Internal Medicine. 1999;130(6):461–470. doi: 10.7326/0003-4819-130-6-199903160-00002.
    1. Zittermann A., Kuhn J., Dreier J., Knabbe C., Gummert J. F., Börgermann J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. European Heart Journal. 2013;34(18):1358–1364. doi: 10.1093/eurheartj/ehs468.
    1. Zittermann A., Kuhn J., Ernst J. B., et al. 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and postoperative outcome in cardiac surgery. Journal of Clinical Endocrinology and Metabolism. 2015;100(1):72–80. doi: 10.1210/jc.20143013.
    1. Souberbielle J.-C., Body J.-J., Lappe J. M., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmunity Reviews. 2010;9(11):709–715. doi: 10.1016/j.autrev.2010.06.009.
    1. Holick M. F., Binkley N. C., Bischoff-Ferrari H. A., et al. Evaluation, treatment, and prevention of vitamin d deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2011;96(7):1911–1930. doi: 10.1210/jc.2011-0385.
    1. Aucella F., Scalzulli R. P., Gatta G., Vigilante M., Carella A. M., Stallone C. Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo. Nephron Clinical Practice. 2003;95(4):c121–c127. doi: 10.1159/000074837.
    1. Alon D. B., Chaimovitz C., Dvilansky A., et al. Novel role of 1,25(OH)2D3 in induction of erythroid progenitor cell proliferation. Experimental Hematology. 2002;30(5):403–409. doi: 10.1016/s0301-472x(02)00789-0.
    1. Zittermann A., Ernst J. B., Birschmann I., Dittrich M. Effect of vitamin D or activated vitamin D on circulating 1,25-dihydroxyvitamin D concentrations: a systematic review and metaanalysis of randomized controlled trials. Clinical Chemistry. 2015;61(12):1484–1494. doi: 10.1373/clinchem.2015.244913.
    1. Liu T., Zhong S., Liu L., et al. Vitamin D deficiency and the risk of anemia: a meta-analysis of observational studies. Renal Failure. 2015;37(6):929–934. doi: 10.3109/0886022X.2015.1052979.
    1. Hirani V., Cumming R. G., Blyth F., et al. Cross-sectional and longitudinal associations between the active vitamin D metabolite (1,25 dihydroxyvitamin D) and haemoglobin levels in older Australian men: the Concord Health and Ageing in Men Project. Age. 2015;37, article 8 doi: 10.1007/s11357-015-9749-1.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe